Evaluation of muscular apoptotic changes and myogenin gene expression in experimental trichinosis after stem cells and atorvastatin added to ivermectin treatment

IF 1.4 4区 医学 Q3 PARASITOLOGY
Zeinab R. Hassan , Samar El-Sayed , Kareman M. Zekry , Samah G. Ahmed , Asmaa Hassan Abd_Elhamid , Doaa E.A. Salama , Azza Kamal Taha , Nihal A. Mahmoud , Shaymaa Fathy Mohammed , Mona M. Amin , Rasha Elsayed Mohamed , Ayat M.S. Eraque , Shimaa A. Mohamed , Ranya M. Abdelgalil , Shimaa Attia Atta , Nermeen Talaat Fahmy , Mohamed S. Badr
{"title":"Evaluation of muscular apoptotic changes and myogenin gene expression in experimental trichinosis after stem cells and atorvastatin added to ivermectin treatment","authors":"Zeinab R. Hassan ,&nbsp;Samar El-Sayed ,&nbsp;Kareman M. Zekry ,&nbsp;Samah G. Ahmed ,&nbsp;Asmaa Hassan Abd_Elhamid ,&nbsp;Doaa E.A. Salama ,&nbsp;Azza Kamal Taha ,&nbsp;Nihal A. Mahmoud ,&nbsp;Shaymaa Fathy Mohammed ,&nbsp;Mona M. Amin ,&nbsp;Rasha Elsayed Mohamed ,&nbsp;Ayat M.S. Eraque ,&nbsp;Shimaa A. Mohamed ,&nbsp;Ranya M. Abdelgalil ,&nbsp;Shimaa Attia Atta ,&nbsp;Nermeen Talaat Fahmy ,&nbsp;Mohamed S. Badr","doi":"10.1016/j.exppara.2024.108823","DOIUrl":null,"url":null,"abstract":"<div><p>Trichinosis is a common parasitic disease that affects the striated skeletal muscles, causing apoptotic and degenerative changes associated with myogenin expression in the affected myocytes. Hence, this study aimed to assess the ameliorative effects of stem cells and atorvastatin added to ivermectin on the infected myocytes during the muscular phase of murine trichinosis. 120 laboratory <em>Swiss albino</em> male mice were divided into 10 groups, and each group was subdivided into intestinal and muscular phases (each n = 6); uninfected control; untreated infected control; infected received ivermectin monotherapy; infected received atorvastatin monotherapy; infected received stem cells monotherapy; infected received ivermectin and atorvastatin dual therapy; infected received ivermectin and stem cells dual therapy; infected received atorvastatin and stem cells dual therapy; infected received ivermectin 0.2, atorvastatin 40, and stem cells triple therapy; and infected received ivermectin 0.1, atorvastatin 20, and stem cells triple therapy. Intestinal phase mice were sacrificed on the 5th day post-infection, while those of the muscular phase were sacrificed on the 35th day post-infection. Parasitological, histopathological, ultrastructural, histochemical, biochemical, and myogenin gene expression assessments were performed. The results revealed that mice that received ivermectin, atorvastatin, and stem cell triple therapies showed the maximum reduction in the adult worm and larvae burden, marked improvement in the underlying muscular degenerative changes (as was noticed by histopathological, ultrastructural, and histochemical Feulgen stain assessment), lower biochemical levels of serum NK-κB and tissue NO, and lower myogenin expression. Accordingly, the combination of stem cells, atorvastatin, and ivermectin affords a potential synergistic activity against trichinosis with considerable healing of the underlying degenerative sequel.</p></div>","PeriodicalId":12117,"journal":{"name":"Experimental parasitology","volume":"265 ","pages":"Article 108823"},"PeriodicalIF":1.4000,"publicationDate":"2024-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental parasitology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014489424001267","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PARASITOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Trichinosis is a common parasitic disease that affects the striated skeletal muscles, causing apoptotic and degenerative changes associated with myogenin expression in the affected myocytes. Hence, this study aimed to assess the ameliorative effects of stem cells and atorvastatin added to ivermectin on the infected myocytes during the muscular phase of murine trichinosis. 120 laboratory Swiss albino male mice were divided into 10 groups, and each group was subdivided into intestinal and muscular phases (each n = 6); uninfected control; untreated infected control; infected received ivermectin monotherapy; infected received atorvastatin monotherapy; infected received stem cells monotherapy; infected received ivermectin and atorvastatin dual therapy; infected received ivermectin and stem cells dual therapy; infected received atorvastatin and stem cells dual therapy; infected received ivermectin 0.2, atorvastatin 40, and stem cells triple therapy; and infected received ivermectin 0.1, atorvastatin 20, and stem cells triple therapy. Intestinal phase mice were sacrificed on the 5th day post-infection, while those of the muscular phase were sacrificed on the 35th day post-infection. Parasitological, histopathological, ultrastructural, histochemical, biochemical, and myogenin gene expression assessments were performed. The results revealed that mice that received ivermectin, atorvastatin, and stem cell triple therapies showed the maximum reduction in the adult worm and larvae burden, marked improvement in the underlying muscular degenerative changes (as was noticed by histopathological, ultrastructural, and histochemical Feulgen stain assessment), lower biochemical levels of serum NK-κB and tissue NO, and lower myogenin expression. Accordingly, the combination of stem cells, atorvastatin, and ivermectin affords a potential synergistic activity against trichinosis with considerable healing of the underlying degenerative sequel.

Abstract Image

在伊维菌素治疗中加入干细胞和阿托伐他汀后,对实验性旋毛虫病肌肉凋亡变化和肌原蛋白基因表达的评估
旋毛虫病是一种常见的寄生虫病,会影响骨骼横纹肌,导致凋亡和退行性变化,并与受影响肌细胞中肌原蛋白的表达有关。因此,本研究旨在评估在伊维菌素中添加干细胞和阿托伐他汀对小鼠旋毛虫病肌肉期受感染肌细胞的改善作用。将120只实验用瑞士白化雄性小鼠分为10组,每组又分为肠道期和肌肉期(每组n = 6);未感染对照组;未治疗的感染对照组;接受伊维菌素单一疗法的感染组;接受阿托伐他汀单一疗法的感染组;接受干细胞单一疗法的感染组;接受伊维菌素和阿托伐他汀双重疗法的感染组;接受伊维菌素和干细胞双重疗法的感染组;接受阿托伐他汀和干细胞双重疗法的感染组;接受伊维菌素0.2、阿托伐他汀 40 和干细胞三联疗法;感染后接受伊维菌素 0.1、阿托伐他汀 20 和干细胞三联疗法。肠道期小鼠在感染后第 5 天处死,肌肉期小鼠在感染后第 35 天处死。对小鼠进行寄生虫学、组织病理学、超微结构、组织化学、生物化学和肌原蛋白基因表达评估。结果显示,接受伊维菌素、阿托伐他汀和干细胞三联疗法的小鼠成虫和幼虫数量减少最多,潜在的肌肉退行性病变明显改善(组织病理学、超微结构和组织化学Feulgen染色评估),血清NK-κB和组织NO的生化水平降低,肌原蛋白表达降低。因此,干细胞、阿托伐他汀和伊维菌素的组合对毛滴虫病具有潜在的协同作用,可显著治愈潜在的退行性后遗症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Experimental parasitology
Experimental parasitology 医学-寄生虫学
CiteScore
3.10
自引率
4.80%
发文量
160
审稿时长
3 months
期刊介绍: Experimental Parasitology emphasizes modern approaches to parasitology, including molecular biology and immunology. The journal features original research papers on the physiological, metabolic, immunologic, biochemical, nutritional, and chemotherapeutic aspects of parasites and host-parasite relationships.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信